Project Grant HT94252510219
Award Date
5/1/25
Completion Date
4/30/28
Dollars Obligated
$954K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Cambridge, MA 02139, USA
Similar Awards
The Defense Health Agency awarded Dana-Farber Cancer Institute a $1,046,135 project grant under the Military Medical Research and Development program to conduct research titled "Drugging the Undruggable: Programming Ovarian Cancer Cells as the Next-Generation Immunotherapy." The three-year award runs from May 15, 2023 to May 14, 2026. As the prime recipient, Dana-Farber will leverage its expertise in tumor biology, immunology and drug development to research new therapies for ovarian...
The Massachusetts Institute of Technology (MIT) received a $619,846 Project Grant award from the Department of the Army Medical Command through the Military Medical Research and Development program (CFDA 12.420). The two-year project, beginning June 1, 2021 and concluding May 31, 2023, will support research to interrogate requisite niche factors for leukemia cell survival at single-cell resolution. Through this funding, MIT researchers will investigate medical solutions for the battlefield by...
The Defense Health Agency awarded a $784,602 Project Grant to Dana-Farber Cancer Institute, Inc. (doing business as Dfci) under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from January 2023 to January 2026 to develop next-generation immunotherapy for breast cancer by turning breast cancer cells against themselves. The Military Medical Research and Development program aims to transform military and public health through innovative medical...
The Massachusetts Institute of Technology (MIT) has been awarded a $1,589,772 federal Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420). The grant, effective September 1, 2024 through August 31, 2027, will fund the development of a novel mHealth balance assessment and rehabilitation system for Neurofibromatosis Type 2 (NF2) using computer vision and artificial intelligence technologies. The project aims to transform healthcare for...
The Massachusetts Institute of Technology (MIT) received a $881,491 Project Grant award from the Department of the Army Medical Command through its Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through September 2024 to elucidate the mechanisms of spotted fever group rickettsia pathogenesis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and...
The Department of Defense's Defense Health Agency awarded a $558,832 Project Grant to Tufts University School of Medicine under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2024. This grant will support research focused on "Targeting Differentiation Epitope in CD11b of Tumor-Associated Inflammatory Monocytes: A Novel Adjuvant Dendritic Cell Therapy Approach for Mucosal Melanoma." The research aims to develop an innovative dendritic cell-based...
The Defense Health Agency awarded a $778,092 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Dana-Farber Cancer Institute, Inc. (DFCI) for the purpose of "ADVANCING PRECLINICAL STUDIES OF DUAL-TARGETED FINE-TUNED IMMUNE-RESTORING (DFIR) CAR-T CELL THERAPY TO ACHIEVE CURES OF HIGH-GRADE SEROUS OVARIAN CANCER." The project aims to conduct preclinical studies on a novel dual-targeted CAR-T cell therapy approach to treat high-grade serous...
The Massachusetts Institute of Technology (MIT) was awarded a $1,761,671 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund MIT's "HIGHLY MULTIPLEXED DETECTION OF IMMUNE RESPONSES TO EMERGING INFECTIOUS DISEASES VIA LENTIVIRAL SURFACE DISPLAY" project from July 1, 2022 to June 30, 2025. Through this research, MIT aims to develop new techniques for rapidly detecting immune responses...
The University of Pittsburgh was awarded a $954,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from May 2023 to May 2026 aimed at epigenetic reprogramming to target senescent ovarian cancer cells and overcome therapeutic resistance. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The Massachusetts Institute of Technology (MIT) was awarded a $1,551,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support MIT's development of a strain-programmable bioadhesive patch for accelerated healing of diabetic ulcers from July 1, 2021 to June 30, 2025. The Military Medical Research and Development program aims to transform military and public health through innovative medical...